{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T00:02:00Z","timestamp":1771545720245,"version":"3.50.1"},"reference-count":61,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T00:00:00Z","timestamp":1770681600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T00:00:00Z","timestamp":1771459200000},"content-version":"vor","delay-in-days":9,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Chinese Cardiovascular Association-Natural lipid-lowering drugs fund","award":["2023-CCA-NLD-563"],"award-info":[{"award-number":["2023-CCA-NLD-563"]}]},{"name":"the Key research and development Program of Zhejiang Province","award":["2025C02116"],"award-info":[{"award-number":["2025C02116"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Ovarian Res"],"DOI":"10.1186\/s13048-026-02019-8","type":"journal-article","created":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T13:37:18Z","timestamp":1770730638000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Integrative metabolomics and proteomics reveal early cardiovascular risk signatures in PCOS female offspring"],"prefix":"10.1186","volume":"19","author":[{"given":"Xinyue","family":"Wu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiangning","family":"Deng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuangying","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aqiong","family":"Xie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yingzhi","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haining","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yimin","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Minyue","family":"Tang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,2,10]]},"reference":[{"key":"2019_CR1","doi-asserted-by":"publisher","first-page":"2841","DOI":"10.1093\/humrep\/dew218","volume":"31","author":"G Bozdag","year":"2016","unstructured":"Bozdag G, Mumusoglu S, Zengin D, Karabulut E, Yildiz BO. The prevalence and phenotypic features of polycystic ovary syndrome: a systematic review and meta-analysis. Hum Reprod. 2016;31:2841\u201355.","journal-title":"Hum Reprod"},{"key":"2019_CR2","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1093\/humrep\/dep399","volume":"25","author":"WA March","year":"2010","unstructured":"March WA, Moore VM, Willson KJ, Phillips DI, Norman RJ, Davies MJ. The prevalence of polycystic ovary syndrome in a community sample assessed under contrasting diagnostic criteria. Hum Reprod. 2010;25:544\u201351.","journal-title":"Hum Reprod"},{"key":"2019_CR3","doi-asserted-by":"publisher","first-page":"e3054","DOI":"10.1002\/dmrr.3054","volume":"34","author":"M Jacewicz-\u015awi\u0119cka","year":"2018","unstructured":"Jacewicz-\u015awi\u0119cka M, Kowalska I. Polycystic ovary syndrome and the risk of cardiometabolic complications in longitudinal studies. Diabetes Metab Res Rev. 2018;34:e3054.","journal-title":"Diabetes Metab Res Rev"},{"key":"2019_CR4","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1093\/humupd\/dmq001","volume":"16","author":"LJ Moran","year":"2010","unstructured":"Moran LJ, Misso ML, Wild RA, Norman RJ. Impaired glucose tolerance, type 2 diabetes and metabolic syndrome in polycystic ovary syndrome: a systematic review and meta-analysis. Hum Reprod Update. 2010;16:347\u201363.","journal-title":"Hum Reprod Update"},{"key":"2019_CR5","first-page":"1560","volume":"31","author":"Z Wan","year":"2024","unstructured":"Wan Z, Zhao J, Ye Y, Sun Z, Li K, Chen Y, et al. Risk and incidence of cardiovascular disease associated with polycystic ovary syndrome. Eur J Prev Cardiol. 2024;31:1560\u201370.","journal-title":"Eur J Prev Cardiol"},{"key":"2019_CR6","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1093\/humupd\/dmz036","volume":"26","author":"MN Gunning","year":"2020","unstructured":"Gunning MN, Sir Petermann T, Crisosto N, van Rijn BB, de Wilde MA, Christ JP, et al. Cardiometabolic health in offspring of women with PCOS compared to healthy controls: a systematic review and individual participant data meta-analysis. Hum Reprod Update. 2020;26:103\u201317.","journal-title":"Hum Reprod Update"},{"key":"2019_CR7","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.mce.2015.11.030","volume":"435","author":"M Puttabyatappa","year":"2016","unstructured":"Puttabyatappa M, Cardoso RC, Padmanabhan V. Effect of maternal PCOS and PCOS-like phenotype on the offspring\u2019s health. Mol Cell Endocrinol. 2016;435:29\u201339.","journal-title":"Mol Cell Endocrinol"},{"key":"2019_CR8","doi-asserted-by":"publisher","first-page":"1711","DOI":"10.1093\/humrep\/deaa125","volume":"35","author":"J Li","year":"2020","unstructured":"Li J, Cui L, Jiang X, Zhao H, Zhao S, Shi Y, et al. Transmission of polycystic ovary syndrome susceptibility single-nucleotide polymorphisms and their association with phenotype changes in offspring. Hum Reprod. 2020;35:1711\u20138.","journal-title":"Hum Reprod"},{"key":"2019_CR9","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1136\/bmj.298.6673.564","volume":"298","author":"DJ Barker","year":"1989","unstructured":"Barker DJ, Osmond C, Golding J, Kuh D, Wadsworth ME. Growth in utero, blood pressure in childhood and adult life, and mortality from cardiovascular disease. BMJ. 1989;298:564\u20137.","journal-title":"BMJ"},{"key":"2019_CR10","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1017\/S2040174415001324","volume":"6","author":"AJ Kermack","year":"2015","unstructured":"Kermack AJ, Van Rijn BB, Houghton FD, Calder PC, Cameron IT, Macklon NS. The \u201cDevelopmental origins\u201d hypothesis: relevance to the obstetrician and gynecologist. J Dev Orig Health Dis. 2015;6:415\u201324.","journal-title":"J Dev Orig Health Dis"},{"key":"2019_CR11","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1161\/HYPERTENSIONAHA.113.02671","volume":"63","author":"R Gaillard","year":"2014","unstructured":"Gaillard R, Steegers EA, Duijts L, Felix JF, Hofman A, Franco OH, et al. Childhood cardiometabolic outcomes of maternal obesity during pregnancy: the Generation R study. Hypertension. 2014;63:683\u201391.","journal-title":"Hypertension"},{"key":"2019_CR12","doi-asserted-by":"publisher","first-page":"804","DOI":"10.1038\/s41588-019-0403-1","volume":"51","author":"NM Warrington","year":"2019","unstructured":"Warrington NM, Beaumont RN, Horikoshi M, Day FR, Helgeland \u00d8, Laurin C, et al. Maternal and fetal genetic effects on birth weight and their relevance to cardio-metabolic risk factors. Nat Genet. 2019;51:804\u201314.","journal-title":"Nat Genet"},{"key":"2019_CR13","doi-asserted-by":"publisher","first-page":"506","DOI":"10.5468\/ogs.2017.60.6.506","volume":"60","author":"EJ Kwon","year":"2017","unstructured":"Kwon EJ, Kim YJ. What is fetal programming?: a lifetime health is under the control of in utero health. Obstet Gynecol Sci. 2017;60:506\u201319.","journal-title":"Obstet Gynecol Sci"},{"key":"2019_CR14","doi-asserted-by":"publisher","first-page":"1923","DOI":"10.1210\/jc.2008-2836","volume":"94","author":"T Sir-Petermann","year":"2009","unstructured":"Sir-Petermann T, Codner E, P\u00e9rez V, Echibur\u00fa B, Maliqueo M, de Ladr\u00f3n Guevara A, et al. Metabolic and reproductive features before and during puberty in daughters of women with polycystic ovary syndrome. J Clin Endocrinol Metab. 2009;94:1923\u201330.","journal-title":"J Clin Endocrinol Metab"},{"key":"2019_CR15","doi-asserted-by":"publisher","first-page":"1275","DOI":"10.1016\/j.fertnstert.2020.02.005","volume":"113","author":"M Sun","year":"2020","unstructured":"Sun M, Sun B, Qiao S, Feng X, Li Y, Zhang S, et al. Elevated maternal androgen is associated with dysfunctional placenta and lipid disorder in newborns of mothers with polycystic ovary syndrome. Fertil Steril. 2020;113:1275-1285.e1272.","journal-title":"Fertil Steril"},{"key":"2019_CR16","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.cmet.2016.09.018","volume":"25","author":"CB Newgard","year":"2017","unstructured":"Newgard CB. Metabolomics and metabolic diseases: where do we stand? Cell Metab. 2017;25:43\u201356.","journal-title":"Cell Metab"},{"key":"2019_CR17","doi-asserted-by":"publisher","first-page":"1613","DOI":"10.1161\/CIRCRESAHA.120.315898","volume":"126","author":"ZZ Chen","year":"2020","unstructured":"Chen ZZ, Gerszten RE. Metabolomics and Proteomics in Type 2 Diabetes. Circ Res. 2020;126:1613\u201327.","journal-title":"Circ Res"},{"key":"2019_CR18","doi-asserted-by":"publisher","first-page":"1819","DOI":"10.1152\/physrev.00035.2018","volume":"99","author":"DS Wishart","year":"2019","unstructured":"Wishart DS. Metabolomics for investigating physiological and pathophysiological processes. Physiol Rev. 2019;99:1819\u201375.","journal-title":"Physiol Rev"},{"key":"2019_CR19","doi-asserted-by":"publisher","first-page":"1238","DOI":"10.1161\/CIRCRESAHA.117.311002","volume":"122","author":"RW McGarrah","year":"2018","unstructured":"McGarrah RW, Crown SB, Zhang GF, Shah SH, Newgard CB. Cardiovascular metabolomics. Circ Res. 2018;122:1238\u201358.","journal-title":"Circ Res"},{"key":"2019_CR20","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1152\/physrev.00026.2023","volume":"104","author":"OA Karpov","year":"2024","unstructured":"Karpov OA, Stotland A, Raedschelders K, Chazarin B, Ai L, Murray CI, et al. Proteomics of the heart. Physiol Rev. 2024;104:931\u201382.","journal-title":"Physiol Rev"},{"key":"2019_CR21","doi-asserted-by":"publisher","first-page":"7817","DOI":"10.1038\/s41467-023-43575-7","volume":"14","author":"J You","year":"2023","unstructured":"You J, Guo Y, Zhang Y, Kang JJ, Wang LB, Feng JF, et al. Plasma proteomic profiles predict individual future health risk. Nat Commun. 2023;14:7817.","journal-title":"Nat Commun"},{"key":"2019_CR22","doi-asserted-by":"crossref","unstructured":"Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil Steril 2004, 81:19-25.","DOI":"10.1016\/j.fertnstert.2003.10.004"},{"key":"2019_CR23","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1186\/s12887-017-0868-y","volume":"17","author":"TRH Nielsen","year":"2017","unstructured":"Nielsen TRH, Lausten-Thomsen U, Fonvig CE, B\u00f8js\u00f8e C, Pedersen L, Bratholm PS, et al. Dyslipidemia and reference values for fasting plasma lipid concentrations in Danish\/North-European White children and adolescents. BMC Pediatr. 2017;17:116.","journal-title":"BMC Pediatr"},{"key":"2019_CR24","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1210\/clinem\/dgz010","volume":"105","author":"MJ Johansen","year":"2020","unstructured":"Johansen MJ, Gade J, Stender S, Frithioff-B\u00f8js\u00f8e C, Lund MAV, Chabanova E, et al. The effect of overweight and obesity on liver biochemical markers in children and adolescents. J Clin Endocrinol Metab. 2020;105:430\u201342.","journal-title":"J Clin Endocrinol Metab"},{"key":"2019_CR25","first-page":"538","volume":"20","author":"C Frithioff-B\u00f8js\u00f8e","year":"2019","unstructured":"Frithioff-B\u00f8js\u00f8e C, Lund MAV, Kloppenborg JT, Nielsen TTH, Fonvig CE, Lausten-Thomsen U, et al. Glucose metabolism in children and adolescents: population-based reference values and comparisons to children and adolescents enrolled in obesity treatment. Pediatr Diabetes. 2019;20:538\u201348.","journal-title":"Pediatr Diabetes"},{"key":"2019_CR26","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1089\/met.2008.0034","volume":"6","author":"LE Simental-Mend\u00eda","year":"2008","unstructured":"Simental-Mend\u00eda LE, Rodr\u00edguez-Mor\u00e1n M, Guerrero-Romero F. The product of fasting glucose and triglycerides as surrogate for identifying insulin resistance in apparently healthy subjects. Metab Syndr Relat Disord. 2008;6:299\u2013304.","journal-title":"Metab Syndr Relat Disord"},{"key":"2019_CR27","doi-asserted-by":"publisher","first-page":"e8145","DOI":"10.1161\/JAHA.122.027042","volume":"12","author":"SE Stinson","year":"2023","unstructured":"Stinson SE, Jonsson AE, Andersen MK, Lund MAV, Holm LA, Fonvig CE, et al. High plasma levels of soluble lectin\u2010like oxidized low\u2010density lipoprotein receptor\u20101 are associated with inflammation and cardiometabolic risk profiles in pediatric overweight and obesity. J Am Heart Assoc. 2023;12:e8145.","journal-title":"J Am Heart Assoc"},{"key":"2019_CR28","doi-asserted-by":"crossref","unstructured":"Expert panel on integrated guidelines for cardiovascular health and risk reduction in children and adolescents: summary report. Pediatrics 2011, 128 Suppl 5:S213\u2013256.","DOI":"10.1542\/peds.2009-2107C"},{"key":"2019_CR29","doi-asserted-by":"publisher","first-page":"W652","DOI":"10.1093\/nar\/gkp356","volume":"37","author":"J Xia","year":"2009","unstructured":"Xia J, Psychogios N, Young N, Wishart DS. MetaboAnalyst: a web server for metabolomic data analysis and interpretation. Nucleic Acids Res. 2009;37:W652\u201360.","journal-title":"Nucleic Acids Res"},{"key":"2019_CR30","doi-asserted-by":"publisher","first-page":"D199","DOI":"10.1093\/nar\/gkt1076","volume":"42","author":"M Kanehisa","year":"2014","unstructured":"Kanehisa M, Goto S, Sato Y, Kawashima M, Furumichi M, Tanabe M. Data, information, knowledge and principle: back to metabolism in KEGG. Nucleic Acids Res. 2014;42:D199-205.","journal-title":"Nucleic Acids Res"},{"key":"2019_CR31","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1001\/jamacardio.2023.2231","volume":"8","author":"G Santos-Beneit","year":"2023","unstructured":"Santos-Beneit G, Fern\u00e1ndez-Alvira JM, Tresserra-Rimbau A, Bodega P, de Cos-Gandoy A, de Miguel M, et al. School-based cardiovascular health promotion in adolescents: a cluster randomized clinical trial. JAMA Cardiol. 2023;8:816\u201324.","journal-title":"JAMA Cardiol"},{"key":"2019_CR32","doi-asserted-by":"publisher","first-page":"1570","DOI":"10.1161\/CIRCRESAHA.123.321998","volume":"132","author":"H Pedamallu","year":"2023","unstructured":"Pedamallu H, Zmora R, Perak AM, Allen NB. Life course cardiovascular health: risk factors, outcomes, and interventions. Circ Res. 2023;132:1570\u201383.","journal-title":"Circ Res"},{"key":"2019_CR33","doi-asserted-by":"publisher","DOI":"10.1186\/s12944-024-02425-1","volume":"24","author":"TC Dakal","year":"2025","unstructured":"Dakal TC, Xiao F, Bhusal CK, Sabapathy PC, Segal R, Chen J, et al. Lipids dysregulation in diseases: core concepts, targets and treatment strategies. Lipids Health Dis. 2025;24:61.","journal-title":"Lipids Health Dis"},{"key":"2019_CR34","doi-asserted-by":"publisher","DOI":"10.3390\/ijms242015305","author":"BV Hong","year":"2023","unstructured":"Hong BV, Zheng J, Zivkovic AM. HDL function across the lifespan: from childhood, to pregnancy, to old age. Int J Mol Sci. 2023. https:\/\/doi.org\/10.3390\/ijms242015305.","journal-title":"Int J Mol Sci"},{"key":"2019_CR35","doi-asserted-by":"publisher","first-page":"4637","DOI":"10.1210\/jc.2007-1036","volume":"92","author":"T Sir-Petermann","year":"2007","unstructured":"Sir-Petermann T, Maliqueo M, Codner E, Echibur\u00fa B, Crisosto N, P\u00e9rez V, et al. Early metabolic derangements in daughters of women with polycystic ovary syndrome. J Clin Endocrinol Metab. 2007;92:4637\u201342.","journal-title":"J Clin Endocrinol Metab"},{"key":"2019_CR36","doi-asserted-by":"publisher","first-page":"1492","DOI":"10.1177\/1933719117749761","volume":"25","author":"MA Wilde","year":"2018","unstructured":"Wilde MA, Eising JB, Gunning MN, Koster MPH, Evelein AMV, Dalmeijer GW, et al. Cardiovascular and metabolic health of 74 children from women previously diagnosed with polycystic ovary syndrome in comparison with a population-based reference cohort. Reprod Sci. 2018;25:1492\u2013500.","journal-title":"Reprod Sci"},{"key":"2019_CR37","doi-asserted-by":"publisher","first-page":"804","DOI":"10.1111\/j.1741-3737.2011.00846.x","volume":"73","author":"BN Horwitz","year":"2011","unstructured":"Horwitz BN, Neiderhiser JM. Gene - environment interplay, family relationships, and child adjustment. J Marriage Fam. 2011;73:804\u201316.","journal-title":"J Marriage Fam"},{"key":"2019_CR38","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1016\/j.cmet.2021.01.004","volume":"33","author":"NEH Mimouni","year":"2021","unstructured":"Mimouni NEH, Paiva I, Barbotin AL, Timzoura FE, Plassard D, Le Gras S, et al. Polycystic ovary syndrome is transmitted via a transgenerational epigenetic process. Cell Metab. 2021;33:513-530.e518.","journal-title":"Cell Metab"},{"key":"2019_CR39","doi-asserted-by":"publisher","first-page":"1666","DOI":"10.1093\/humrep\/deaa099","volume":"35","author":"G Mills","year":"2020","unstructured":"Mills G, Badeghiesh A, Suarthana E, Baghlaf H, Dahan MH. Polycystic ovary syndrome as an independent risk factor for gestational diabetes and hypertensive disorders of pregnancy: a population-based study on 9.1 million pregnancies. Hum Reprod. 2020;35:1666\u201374.","journal-title":"Hum Reprod"},{"key":"2019_CR40","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1016\/j.diabres.2007.03.023","volume":"78","author":"H Lee","year":"2007","unstructured":"Lee H, Jang HC, Park HK, Cho NH. Early manifestation of cardiovascular disease risk factors in offspring of mothers with previous history of gestational diabetes mellitus. Diabetes Res Clin Pract. 2007;78:238\u201345.","journal-title":"Diabetes Res Clin Pract"},{"key":"2019_CR41","doi-asserted-by":"publisher","first-page":"1569","DOI":"10.1093\/eurheartj\/ehac055","volume":"43","author":"NS Nurmohamed","year":"2022","unstructured":"Nurmohamed NS, Belo Pereira JP, Hoogeveen RM, Kroon J, Kraaijenhof JM, Waissi F, et al. Targeted proteomics improves cardiovascular risk prediction in secondary prevention. Eur Heart J. 2022;43:1569\u201377.","journal-title":"Eur Heart J"},{"key":"2019_CR42","doi-asserted-by":"publisher","first-page":"3998","DOI":"10.1093\/eurheartj\/ehaa648","volume":"41","author":"RM Hoogeveen","year":"2020","unstructured":"Hoogeveen RM, Pereira JPB, Nurmohamed NS, Zampoleri V, Bom MJ, Baragetti A, et al. Improved cardiovascular risk prediction using targeted plasma proteomics in primary prevention. Eur Heart J. 2020;41:3998\u20134007.","journal-title":"Eur Heart J"},{"key":"2019_CR43","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1186\/s12964-018-0268-4","volume":"16","author":"MM Zegeye","year":"2018","unstructured":"Zegeye MM, Lindkvist M, F\u00e4lker K, Kumawat AK, Paramel G, Greneg\u00e5rd M, et al. Activation of the JAK\/STAT3 and PI3K\/AKT pathways are crucial for IL-6 trans-signaling-mediated pro-inflammatory response in human vascular endothelial cells. Cell Commun Signal. 2018;16:55.","journal-title":"Cell Commun Signal"},{"key":"2019_CR44","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1186\/s12931-018-0829-5","volume":"19","author":"AD Rieg","year":"2018","unstructured":"Rieg AD, Suleiman S, Anker C, Verjans E, Rossaint R, Uhlig S, et al. PDGF-BB regulates the pulmonary vascular tone: impact of prostaglandins, calcium, MAPK- and PI3K\/AKT\/mTOR signalling and actin polymerisation in pulmonary veins of guinea pigs. Respir Res. 2018;19:120.","journal-title":"Respir Res"},{"key":"2019_CR45","doi-asserted-by":"publisher","DOI":"10.3390\/ijms20051149","author":"SH Law","year":"2019","unstructured":"Law SH, Chan ML, Marathe GK, Parveen F, Chen CH, Ke LY. An updated review of lysophosphatidylcholine metabolism in human diseases. Int J Mol Sci. 2019. https:\/\/doi.org\/10.3390\/ijms20051149.","journal-title":"Int J Mol Sci"},{"key":"2019_CR46","doi-asserted-by":"publisher","first-page":"1248","DOI":"10.1053\/j.gastro.2023.02.023","volume":"164","author":"M Thiele","year":"2023","unstructured":"Thiele M, Suvitaival T, Tro\u0161t K, Kim M, de Zawadzki A, Kjaergaard M, et al. Sphingolipids are depleted in alcohol-related liver fibrosis. Gastroenterology. 2023;164:1248\u201360.","journal-title":"Gastroenterology"},{"key":"2019_CR47","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1038\/s41591-024-03279-x","volume":"31","author":"Y Huang","year":"2025","unstructured":"Huang Y, Sulek K, Stinson SE, Holm LA, Kim M, Trost K, et al. Lipid profiling identifies modifiable signatures of cardiometabolic risk in children and adolescents with obesity. Nat Med. 2025;31:294\u2013305.","journal-title":"Nat Med"},{"key":"2019_CR48","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1093\/cvr\/cvaa211","volume":"117","author":"L Liberale","year":"2021","unstructured":"Liberale L, Montecucco F, Schwarz L, L\u00fcscher TF, Camici GG. Inflammation and cardiovascular diseases: lessons from seminal clinical trials. Cardiovasc Res. 2021;117:411\u201322.","journal-title":"Cardiovasc Res"},{"key":"2019_CR49","doi-asserted-by":"publisher","first-page":"108238","DOI":"10.1016\/j.pharmthera.2022.108238","volume":"237","author":"J Cai","year":"2022","unstructured":"Cai J, Rimal B, Jiang C, Chiang JYL, Patterson AD. Bile acid metabolism and signaling, the microbiota, and metabolic disease. Pharmacol Ther. 2022;237:108238.","journal-title":"Pharmacol Ther"},{"key":"2019_CR50","doi-asserted-by":"publisher","first-page":"1574","DOI":"10.1002\/hep.29857","volume":"68","author":"P Pathak","year":"2018","unstructured":"Pathak P, Xie C, Nichols RG, Ferrell JM, Boehme S, Krausz KW, et al. Intestine farnesoid X receptor agonist and the gut microbiota activate G-protein bile acid receptor-1 signaling to improve metabolism. Hepatology. 2018;68:1574\u201388.","journal-title":"Hepatology"},{"key":"2019_CR51","doi-asserted-by":"publisher","first-page":"108480","DOI":"10.1016\/j.pharmthera.2023.108480","volume":"249","author":"S Hummelgaard","year":"2023","unstructured":"Hummelgaard S, Vilstrup JP, Gustafsen C, Glerup S, Weyer K. Targeting PCSK9 to tackle cardiovascular disease. Pharmacol Ther. 2023;249:108480.","journal-title":"Pharmacol Ther"},{"key":"2019_CR52","doi-asserted-by":"publisher","first-page":"103612","DOI":"10.1016\/j.etap.2021.103612","volume":"84","author":"A Bizo\u0144","year":"2021","unstructured":"Bizo\u0144 A, Franik G, Madej P. The role of proprotein convertase subtilisin\/kexin type-9 concentration and paraoxonase 1 activities in the blood of women with polycystic ovary syndrome. Environ Toxicol Pharmacol. 2021;84:103612.","journal-title":"Environ Toxicol Pharmacol"},{"key":"2019_CR53","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.metabol.2019.02.002","volume":"94","author":"M Wang","year":"2019","unstructured":"Wang M, Zhao D, Xu L, Guo W, Nie L, Lei Y, et al. Role of PCSK9 in lipid metabolic disorders and ovarian dysfunction in polycystic ovary syndrome. Metabolism. 2019;94:47\u201358.","journal-title":"Metabolism"},{"key":"2019_CR54","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1055\/s-0040-1715897","volume":"121","author":"PCS van Paridon","year":"2021","unstructured":"van Paridon PCS, Panova-Noeva M, van Oerle R, Schulz A, Prochaska JH, Arnold N, et al. Relation between tissue factor pathway inhibitor activity and cardiovascular risk factors and diseases in a large population sample. Thromb Haemost. 2021;121:174\u201381.","journal-title":"Thromb Haemost"},{"key":"2019_CR55","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1160\/TH06-08-0454","volume":"97","author":"A Babinska","year":"2007","unstructured":"Babinska A, Azari BM, Salifu MO, Liu R, Jiang XC, Sobocka MB, et al. The F11 receptor (F11R\/JAM-A) in atherothrombosis: overexpression of F11R in atherosclerotic plaques. Thromb Haemost. 2007;97:272\u201381.","journal-title":"Thromb Haemost"},{"key":"2019_CR56","doi-asserted-by":"crossref","first-page":"294","DOI":"10.3389\/fphys.2014.00294","volume":"5","author":"P von Hundelshausen","year":"2014","unstructured":"von Hundelshausen P, Schmitt MM. Platelets and their chemokines in atherosclerosis-clinical applications. Front Physiol. 2014;5:294.","journal-title":"Front Physiol"},{"key":"2019_CR57","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1038\/s41419-024-06775-7","volume":"15","author":"T Huang","year":"2024","unstructured":"Huang T, Cao H, Liu C, Sun X, Dai S, Liu L, et al. MAL2 reprograms lipid metabolism in intrahepatic cholangiocarcinoma via EGFR\/SREBP-1 pathway based on single-cell RNA sequencing. Cell Death Dis. 2024;15:411.","journal-title":"Cell Death Dis"},{"key":"2019_CR58","doi-asserted-by":"publisher","first-page":"108112","DOI":"10.1016\/j.pharmthera.2022.108112","volume":"236","author":"S Kimura","year":"2022","unstructured":"Kimura S, Yokoyama S, Pilon AL, Kurotani R. Emerging role of an immunomodulatory protein secretoglobin 3A2 in human diseases. Pharmacol Ther. 2022;236:108112.","journal-title":"Pharmacol Ther"},{"key":"2019_CR59","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1016\/j.ijcard.2015.03.051","volume":"185","author":"TT Laitinen","year":"2015","unstructured":"Laitinen TT, Pahkala K, Magnussen CG, Oikonen M, Viikari JS, Sabin MA, et al. Lifetime measures of ideal cardiovascular health and their association with subclinical atherosclerosis: the Cardiovascular Risk in Young Finns Study. Int J Cardiol. 2015;185:186\u201391.","journal-title":"Int J Cardiol"},{"key":"2019_CR60","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1001\/jamacardio.2020.0140","volume":"5","author":"NB Allen","year":"2020","unstructured":"Allen NB, Krefman AE, Labarthe D, Greenland P, Juonala M, K\u00e4h\u00f6nen M, et al. Cardiovascular health trajectories from childhood through middle age and their association with subclinical atherosclerosis. JAMA Cardiol. 2020;5:557\u201366.","journal-title":"JAMA Cardiol"},{"key":"2019_CR61","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.jpeds.2003.08.015","volume":"144","author":"L Ib\u00e1\u00f1ez","year":"2004","unstructured":"Ib\u00e1\u00f1ez L, Ferrer A, Ong K, Amin R, Dunger D, de Zegher F. Insulin sensitization early after menarche prevents progression from precocious pubarche to polycystic ovary syndrome. J Pediatr. 2004;144:23\u20139.","journal-title":"J Pediatr"}],"container-title":["Journal of Ovarian Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13048-026-02019-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13048-026-02019-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13048-026-02019-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T23:04:28Z","timestamp":1771542268000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13048-026-02019-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,10]]},"references-count":61,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2019"],"URL":"https:\/\/doi.org\/10.1186\/s13048-026-02019-8","relation":{},"ISSN":["1757-2215"],"issn-type":[{"value":"1757-2215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,10]]},"assertion":[{"value":"2 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All sample collection procedures were approved by the Institutional Review Board of Women's Hospital, School of Medicine, Zhejiang University (Approval No. IRB-20220331-R) and written informed consent was obtained from all participants and by a parent or guardian with parental responsibility on behalf of their children.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"72"}}